| Identification | Back Directory | [Name]
1H-Indole-3-propanamide, 5,7-difluoro-2-(4-fluorophenyl)-N-[(3S,4R)-4-hydroxy-2-oxo-3-pyrrolidinyl]- | [CAS]
2446816-88-0 | [Synonyms]
Inaxaplin
1H-Indole-3-propanamide, 5,7-difluoro-2-(4-fluorophenyl)-N-[(3S,4R)-4-hydroxy-2-oxo-3-pyrrolidinyl]-
3-(5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl)-N-((3S,4R)-4-hydroxy-2-oxopyrrolidin-3-yl)propanamide | [Molecular Formula]
C21H18F3N3O3 | [MOL File]
2446816-88-0.mol | [Molecular Weight]
417.38 |
| Chemical Properties | Back Directory | [Boiling point ]
797.6±60.0 °C(Predicted) | [density ]
1.49±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [form ]
Solid | [pka]
13.03±0.40(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Inaxaplin (VX-147) is an orally active apolipoprotein L1 (APOL1) function inhibitor (WO2020131807, compound 2). Inaxaplin can be used for the research of kidney disease[1]. | [storage]
Store at -20°C | [References]
[1] WO2020131807 |
|
|